Patients with IPF (n=165) will be randomised 1:1:1 to receive 200mg or 400mg CC-90001 or placebo administered PO one time per day; up to 25 patients/arm will be permitted concomitant pirfenidone use. Forty-five patients in the PF-ILD substudy will be randomised 2:1 to receive 400mg...
pulmonaryN-terminalkinaseJNK1JNKIPFInhibitorinhibitidiopathichJNK1fibrosisc-JunCC-90001CC90001CC 90001Related Tags: buy CC-90001 | purchase CC-90001 | CC-90001 cost | order CC-90001 | CC-90001 chemical structure | CC-90001 in vivo | CC-90001 in vitro | CC-90001 formula | CC-90001 molecula...